CAMBRIDGE, Mass., June 20, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex mixture drugs, ...
Profiling of a global cohort of 1,250 neuroendocrine tumors to identify multiple potential drug targets. This is an ASCO Meeting Abstract from the 2014 Gastrointestinal Cancers Symposium. This ...
Response rates in patients with relapsed/refractory acute myeloid leukemia with FLT3-ITD mutation using 5-azacitadine plus sorafenib. This is an ASCO Meeting Abstract from the Markers in Cancer. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results